These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 621200)

  • 21. Characterization of an extremely large, ligand-induced conformational change in plasminogen.
    Mangel WF; Lin BH; Ramakrishnan V
    Science; 1990 Apr; 248(4951):69-73. PubMed ID: 2108500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference with dimethylhydrazine induction of colon tumors in mice by epsilon-aminocaproic acid.
    Corasanti JG; Hobika GH; Markus G
    Science; 1982 May; 216(4549):1020-1. PubMed ID: 6805074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptokinase binds preferentially to the extended conformation of plasminogen through lysine binding site and catalytic domain interactions.
    Boxrud PD; Bock PE
    Biochemistry; 2000 Nov; 39(45):13974-81. PubMed ID: 11076540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [COMPARATIVE STUDY ON THE EFFECT OF EPSILON-AMINOCAPROIC ACID, ACETYL-EPSILON-AMINOCAPROIC ACID AND CAPROLACTAM FOR VARIOUS PARAMETERS OF THE FIBRINOLYTIC SYSTEM].
    AUERSWALD W; DOLESCHEL W
    Wien Med Wochenschr; 1965 Feb; 115():102-5. PubMed ID: 14260441
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874.
    Pantzar M; Ljungh A; Wadström T
    Infect Immun; 1998 Oct; 66(10):4976-80. PubMed ID: 9746606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing conjugation of phenolic compounds with the epsilon-amino group.
    Takeuchi Y
    J Dermatol; 1985 Apr; 12(2):153-60. PubMed ID: 3897324
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of the lysine binding sites of human plasminogen in the fibrinogen stimulated rate of active site formation in the streptokinase-plasminogen equimolar complex.
    Smith JH; Morris JP; Chibber BA; Castellino FJ
    Thromb Res; 1984 Jun; 34(6):499-506. PubMed ID: 6429889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus.
    Broeseker TA; Boyle MD; Lottenberg R
    Microb Pathog; 1988 Jul; 5(1):19-27. PubMed ID: 2977421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4.
    Wu TP; Padmanabhan K; Tulinsky A; Mulichak AM
    Biochemistry; 1991 Oct; 30(43):10589-94. PubMed ID: 1657149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location of the intermediate and high affinity omega-aminocarboxylic acid-binding sites in human plasminogen.
    Váli Z; Patthy L
    J Biol Chem; 1982 Feb; 257(4):2104-10. PubMed ID: 6915938
    [No Abstract]   [Full Text] [Related]  

  • 36. Characteristics of plasminogen binding to Trypanosoma cruzi epimastigotes.
    Rojas M; Labrador I; Concepción JL; Aldana E; Avilan L
    Acta Trop; 2008 Jul; 107(1):54-8. PubMed ID: 18501871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the interactions between streptokinase domains and human plasminogen.
    Conejero-Lara F; Parrado J; Azuaga AI; Dobson CM; Ponting CP
    Protein Sci; 1998 Oct; 7(10):2190-9. PubMed ID: 9792107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Aminohexanoic acid-plasminogen interactions studied by fluorescence.
    Vuk-Pavlović S; Gafni A
    Biochem Biophys Res Commun; 1979 Dec; 91(3):971-5. PubMed ID: 526295
    [No Abstract]   [Full Text] [Related]  

  • 39. Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy.
    Thewes T; Constantine K; Byeon IJ; Llinás M
    J Biol Chem; 1990 Mar; 265(7):3906-15. PubMed ID: 2105955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USE OF EPSILON AMINOCAPROIC ACID.
    GANS H
    Surg Gynecol Obstet; 1965 Mar; 120():576-7. PubMed ID: 14262059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.